Program
cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion
Also written as “Cetaphil”, “Facial Cleanser” and “Facial cleanser”.
Its studies are mostly in Psoriasis, led by 2 companies.
Drug pageCetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion: every studyAll 7 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Galderma Groupits history only | 20 open or running | phase 4since Mar 20, 2024 | Mar 20, 2024 | none ahead |
| Revision Skincareits history only | 20 open or running | no phasesince Sep 4, 2020 | Sep 4, 2020 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 4, 2020First study: no phase study in Fine LinesNew to Revision SkincareRevision Skincare · NCT04545970 · 56 enrolled · United States
- Oct 11, 2021No phase study in WrinklesRevision Skincare · NCT05089851 · 29 enrolled · United States
- Mar 20, 2024Galderma Group’s first study: phase 4 study in PsoriasisNew to Galderma GroupGalderma Group · NCT06357221 · 46 enrolled · United States
- Jan 13, 2026Phase 4 study in Crepey SkinGalderma Group · NCT07398989 · 32 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07398989Crepey Skin · United States | 4 | Completed | Galderma Group | Mar 25, 2026 | 32 |
| NCT06357221Psoriasis · United States | 4 | Completed | Galderma Group | Jul 18, 2024 | 46 |
| NCT05089851Wrinkles · United States | – | Completed | Revision Skincare | Jun 3, 2021 | 29 |
| NCT04545970Fine Lines · United States | – | Completed | Revision Skincare | Mar 11, 2020 | 56 |
How it is read
Names in the registry
- “Cetaphil”, 2 entries
- “Facial Cleanser”, 1 entry
- “Facial cleanser”, 1 entry
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.